Cambridge Biomedical

Since our establishment in 1997, Cambridge Biomedical has supported sponsors and CRO?s developing customized assays for small and large molecules, biomarkers, diagnostics, and medical devices. Our team has expertise and extensive experience in technology transfer, assay development, optimization and validation. We are positioned to work with you at preclinical, clinical and post market stages of drug or device development. Mission:?Our mission is to provide the healthcare industry with valid analytical methods and results on which to base efficient product development and patient care decisions.